Chair: Darlene Metter, MD
The Radioactive Drug Research Committee is a joint committee for UT Health Science Center at San Antonio, the Veterans Health Care System, Audie L. Murphy Division and the University Health System with a charge to review all protocols involving the use of research radioactive drugs and/or agents with human subjects. Responsible for ensuring compliance of regulations mandated by the US Food and Drug Administration.
Submissions required for human use research protocols involving radioactive drugs that are not covered under an IND application.
Requirements for Human Use Research involving IRB studies
- A Human Use Research Signature Assurance Sheet
- Research Common Application Step 1
- Research Common Application Step 2 Institutional Form
- Research Common Application Continuation of UTHSCSA IRB Application
- D Consent Form
- Q Radiation Worksheet
All submissions should be received prior to the due date for each Radioactive Drug Research Committee meeting outlined below. The Radiation Safety Committee will review protocols prior to the Radioactive Drug Research Committee meeting on a case by case basis. Please contact Jennifer Cerecero at (210) 567-2960 or email@example.com for any questions or concerns.
|Meeting Date||Due Date*|
|September 8, 2016||August 11, 2016|
|December 8, 2016||November 10, 2016|
|March 9, 2017||February 9, 2017|
|June 8, 2017||May 11, 2017|
*All submissions must be received by 5:00 P.M. on the due date. Nine copies must be submitted at that time.
Jennifer A. Cerecero, MS
Radiation Safety Officer
210-567-2955 (main line)
210-567-2960 (direct line)